| Chantel K Hillestad, FNP-C | |
|
400 Burdick Expy E, Minot, ND 58701-4768 | |
| (701) 857-7382 | |
| (701) 857-7071 |
| Full Name | Chantel K Hillestad |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 13 Years |
| Location | 400 Burdick Expy E, Minot, North Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043508526 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | R31783 (North Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Trinity Hospitals | Minot, ND | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Trinity Health | 7911816020 | 287 |
News Archive
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Europe Ltd., today announced six-year follow-up results from a Phase 3 randomised, open-label, dose-optimisation study of SPRYCEL (dasatinib) in Philadelphia chromosome-positive (Ph+) chronic-phase chronic myeloid leukaemia (CP-CML) adult patients resistant or intolerant to Glivec (imatinib).
Impel NeuroPharma, a medical device company whose technology is designed to enable pharmaceutical drugs to bypass the blood-brain barrier and enter the central nervous system (CNS), today announced that it was selected to receive a Phase II Small Business Investigational Research (SBIR) grant from the Department of Defense's Chemical and Biological Defense SBIR Program entitled, "Blood Brain Barrier Drug Delivery of Therapeutics for Chemical Warfare Agents."
Use of a minimally invasive endoscopic procedure to remove superficial, early stage esophageal cancer is as effective as surgery that takes out and rebuilds the esophagus, according to a study by researchers at Mayo Clinic in Florida. The research, published in Clinical Gastroenterology and Hepatology, examined national outcomes from endoscopic treatment compared to esophagectomy, surgical removal of the esophagus.
We all have at one time or another experienced the typical signs of an infection: the fever, the listlessness, the lack of appetite. They are orchestrated by the brain in response to circulating cytokines, the signaling molecules of the immune system. But just how cytokines' reach extends beyond the almost impenetrable blood-brain barrier has been the topic of much dispute.
Overweight is unhealthy. Yet more and more people in Germany are overweight, particularly children. As part of the LiNA mother-child study coordinated by the Helmholtz Centre for Environmental Research, researchers were able to identify mother's perceived stress during the first year of the child's life as a risk factor for developing overweight in infancy.
› Verified 2 days ago
| Entity Name | Trinity Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083653752 PECOS PAC ID: 7911816020 Enrollment ID: O20031106000316 |
News Archive
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Europe Ltd., today announced six-year follow-up results from a Phase 3 randomised, open-label, dose-optimisation study of SPRYCEL (dasatinib) in Philadelphia chromosome-positive (Ph+) chronic-phase chronic myeloid leukaemia (CP-CML) adult patients resistant or intolerant to Glivec (imatinib).
Impel NeuroPharma, a medical device company whose technology is designed to enable pharmaceutical drugs to bypass the blood-brain barrier and enter the central nervous system (CNS), today announced that it was selected to receive a Phase II Small Business Investigational Research (SBIR) grant from the Department of Defense's Chemical and Biological Defense SBIR Program entitled, "Blood Brain Barrier Drug Delivery of Therapeutics for Chemical Warfare Agents."
Use of a minimally invasive endoscopic procedure to remove superficial, early stage esophageal cancer is as effective as surgery that takes out and rebuilds the esophagus, according to a study by researchers at Mayo Clinic in Florida. The research, published in Clinical Gastroenterology and Hepatology, examined national outcomes from endoscopic treatment compared to esophagectomy, surgical removal of the esophagus.
We all have at one time or another experienced the typical signs of an infection: the fever, the listlessness, the lack of appetite. They are orchestrated by the brain in response to circulating cytokines, the signaling molecules of the immune system. But just how cytokines' reach extends beyond the almost impenetrable blood-brain barrier has been the topic of much dispute.
Overweight is unhealthy. Yet more and more people in Germany are overweight, particularly children. As part of the LiNA mother-child study coordinated by the Helmholtz Centre for Environmental Research, researchers were able to identify mother's perceived stress during the first year of the child's life as a risk factor for developing overweight in infancy.
› Verified 2 days ago
| Entity Name | Minot Health Clinic, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477970846 PECOS PAC ID: 0143449439 Enrollment ID: O20140918001951 |
News Archive
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Europe Ltd., today announced six-year follow-up results from a Phase 3 randomised, open-label, dose-optimisation study of SPRYCEL (dasatinib) in Philadelphia chromosome-positive (Ph+) chronic-phase chronic myeloid leukaemia (CP-CML) adult patients resistant or intolerant to Glivec (imatinib).
Impel NeuroPharma, a medical device company whose technology is designed to enable pharmaceutical drugs to bypass the blood-brain barrier and enter the central nervous system (CNS), today announced that it was selected to receive a Phase II Small Business Investigational Research (SBIR) grant from the Department of Defense's Chemical and Biological Defense SBIR Program entitled, "Blood Brain Barrier Drug Delivery of Therapeutics for Chemical Warfare Agents."
Use of a minimally invasive endoscopic procedure to remove superficial, early stage esophageal cancer is as effective as surgery that takes out and rebuilds the esophagus, according to a study by researchers at Mayo Clinic in Florida. The research, published in Clinical Gastroenterology and Hepatology, examined national outcomes from endoscopic treatment compared to esophagectomy, surgical removal of the esophagus.
We all have at one time or another experienced the typical signs of an infection: the fever, the listlessness, the lack of appetite. They are orchestrated by the brain in response to circulating cytokines, the signaling molecules of the immune system. But just how cytokines' reach extends beyond the almost impenetrable blood-brain barrier has been the topic of much dispute.
Overweight is unhealthy. Yet more and more people in Germany are overweight, particularly children. As part of the LiNA mother-child study coordinated by the Helmholtz Centre for Environmental Research, researchers were able to identify mother's perceived stress during the first year of the child's life as a risk factor for developing overweight in infancy.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chantel K Hillestad, FNP-C Po Box 5010, Minot, ND 58702-5010 Ph: (701) 418-8000 | Chantel K Hillestad, FNP-C 400 Burdick Expy E, Minot, ND 58701-4768 Ph: (701) 857-7382 |
News Archive
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Europe Ltd., today announced six-year follow-up results from a Phase 3 randomised, open-label, dose-optimisation study of SPRYCEL (dasatinib) in Philadelphia chromosome-positive (Ph+) chronic-phase chronic myeloid leukaemia (CP-CML) adult patients resistant or intolerant to Glivec (imatinib).
Impel NeuroPharma, a medical device company whose technology is designed to enable pharmaceutical drugs to bypass the blood-brain barrier and enter the central nervous system (CNS), today announced that it was selected to receive a Phase II Small Business Investigational Research (SBIR) grant from the Department of Defense's Chemical and Biological Defense SBIR Program entitled, "Blood Brain Barrier Drug Delivery of Therapeutics for Chemical Warfare Agents."
Use of a minimally invasive endoscopic procedure to remove superficial, early stage esophageal cancer is as effective as surgery that takes out and rebuilds the esophagus, according to a study by researchers at Mayo Clinic in Florida. The research, published in Clinical Gastroenterology and Hepatology, examined national outcomes from endoscopic treatment compared to esophagectomy, surgical removal of the esophagus.
We all have at one time or another experienced the typical signs of an infection: the fever, the listlessness, the lack of appetite. They are orchestrated by the brain in response to circulating cytokines, the signaling molecules of the immune system. But just how cytokines' reach extends beyond the almost impenetrable blood-brain barrier has been the topic of much dispute.
Overweight is unhealthy. Yet more and more people in Germany are overweight, particularly children. As part of the LiNA mother-child study coordinated by the Helmholtz Centre for Environmental Research, researchers were able to identify mother's perceived stress during the first year of the child's life as a risk factor for developing overweight in infancy.
› Verified 2 days ago
Mrs. Pamela Lacey Leuschen, APRN, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2050 36th Ave Sw Ste 201, Minot, ND 58701 Phone: 701-852-8502 | |
Trisha J Fennern, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1021 20th Ave Sw Ste 113, Minot, ND 58701 Phone: 701-837-1551 Fax: 701-837-1540 | |
Katelyn Jeanne Richter, APRN-FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2111 Landmark Cir Nw, Minot, ND 58703 Phone: 701-858-1800 | |
Hailey R Schiele, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1418 S Broadway Ste B, Minot, ND 58701 Phone: 701-852-9364 | |
Cathleen Hoffman, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 400 Burdick Expy E, Minot, ND 58701 Phone: 701-857-5000 | |
Stacy Nicole Flaten, FNP- BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 407 3rd St Se, Minot, ND 58701 Phone: 701-857-2360 Fax: 701-857-2187 |